APA (7th ed.) Citation

P, L., JF, K., JS, H., S, L., FG, H., WL, C., . . . TY, W. (2025). Plain language summary of publication of the 48-week results from the PULSAR study investigating how well a new dose of aflibercept works and how safe it is for people with wet age-related macular degeneration. Therapeutic advances in ophthalmology, 17, 25158414251356388. https://doi.org/10.1177/25158414251356388

Chicago Style (17th ed.) Citation

P, Lanzetta, et al. "Plain Language Summary of Publication of the 48-week Results from the PULSAR Study Investigating How Well a New Dose of Aflibercept Works and How Safe It Is for People with Wet Age-related Macular Degeneration." Therapeutic Advances in Ophthalmology 17 (2025): 25158414251356388. https://doi.org/10.1177/25158414251356388.

MLA (9th ed.) Citation

P, Lanzetta, et al. "Plain Language Summary of Publication of the 48-week Results from the PULSAR Study Investigating How Well a New Dose of Aflibercept Works and How Safe It Is for People with Wet Age-related Macular Degeneration." Therapeutic Advances in Ophthalmology, vol. 17, 2025, p. 25158414251356388, https://doi.org/10.1177/25158414251356388.